Skip to main content

Cerity Partners LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1566475 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$22,564,723
-$1,677,072 QoQ
Shares Held
349,137
-3.1% QoQ
Ownership
0.294%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 72.83616460014264.ToString("F0")% Shared 7.657166098121941.ToString("F0")% None 19.50666930173542.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Cerity Partners LLC holds $355,640,511 across 116 Biotechnology names. HALO ranks #4 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 HALO
Halozyme Therapeutics, Inc.
This page
349,137 $22,564,723

All Filings in HALO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,564,723 349,137
2025-12-31 $24,241,795 360,205
2025-09-30 $25,544,101 348,297
2025-06-30 $16,953,005 325,894
2025-03-31 $18,561,882 290,893
2024-12-31 $16,009,274 334,852
2024-09-30 $17,159,865 299,788
2024-06-30 $15,239,692 291,056
2024-03-31 $12,022,607 295,541
2023-12-31 $9,961,385 269,518
2023-09-30 $9,673,462 253,232
2023-06-30 $9,310,424 258,121
2023-03-31 $9,760,905 255,588
2022-12-31 $14,753,032 259,280
2022-09-30 $264,918 6,700
2022-06-30 $261,932 5,953